Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
09/2008
09/16/2008US7425639 Process
09/16/2008CA2180101C Process for the preparation of n-substituded glycine acids or glycine esters and use of said process for indigo synthesis
09/12/2008WO2008107661A1 New methylenebisphenyl compounds useful in the treatment of inflammation
09/12/2008WO2008107211A2 Novel p2y12 receptor antagonists
09/12/2008CA2680139A1 New methylenebisphenyl compounds useful in the treatment of inflammation
09/11/2008US20080221497 Filter membrane of polypheylacetylene, or cellulosic or chitin polymers modified with arginine, cysteine, or lysine side chains to remove toxic carbonyl compounds; diabetic and uremic dialysis patients
09/11/2008US20080221298 Fluorinated Diamine and Polymer Made from the Same
09/11/2008US20080221210 3-(3,5-dibromo-4-{[3-(methylamino)benzyl]oxy}phenyl)propanoic acid; hypercholesterolemia, dyslipidemia, obesity, diabetes, atherosclerosis and cardiac diseases
09/11/2008US20080221209 Psoriasis, alopecia, contact dermatitis, atopic dermatitis, allergies, vitiligo or inflammatory skin disorders; esterification reaction of oleyl alcohol and a stereoisomer of phenylglycine chloride hydrochloride in a polar aprotic solvent
09/11/2008US20080221182 Anti-cancer and anti-microbial oxazolidinones
09/11/2008US20080220477 pdCpA is bound to an amino acid such as phenylalanine, tryptophan or tyrosine or derivative allowed to react with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indecene-3-propionic acid label to form a labeled amino acid-pdCpA conjugate, which is then bound to tRNA(CA-); functional protein synthesis
09/11/2008US20080217580 Organic Luminescent Element
09/10/2008EP1967513A1 Novel P2Y12 receptor antagonists
09/10/2008EP1966119A1 Photocrosslinkable materials
09/10/2008EP1368302B1 Novel amino dicarboxylic acid derivatives
09/10/2008EP1285908B1 Substituted phenylpropionic acid derivatives
09/10/2008CN101263108A Process for the preparation of contrast agents
09/10/2008CN101260063A Gamma-aminobutyric acid derivative and its preparing process
09/10/2008CN101260062A Method for synthesizing beta-aminopropenone compounds
09/10/2008CN100417639C Technique of water phase method for preparing Di-SGC
09/09/2008US7423172 3-(p-Substituted alkoxyphenyl)-2-(o-benzoylanilino)propionic acid derivatives, e.g., 2-(o-Benzoylphenylamino)-3-(p-{2-[(o-fluorophenyl)isobutylamino]-ethoxy}phenyl)propionic acid; for treating non-insulin dependent diabetes and obesity
09/09/2008US7423012 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors
09/09/2008CA2412047C Shortened synthesis of 3,3-diarylpropylamine derivatives
09/04/2008WO2008106217A1 Preparation of gabapentin by liquid-liquid extraction
09/04/2008WO2008105386A1 Rexinoid compound having alkoxy group
09/04/2008WO2008082486A3 Preparation of 3-amino-3-(cyclobutylmethyl)-2-(hydroxy)-propionamide hydrochloride
09/04/2008US20080214850 Reacting alkanol amines with defined mixtures of short chain fatty acids and medium/long chain fatty acids and quaternizing the resulting esters with alkylation agents in known manner; cosmetics
09/04/2008US20080214801 Condensation of a specifically engineered phosphine containing a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine by-product and producing an amide bond in final product
09/04/2008US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist
09/04/2008US20080214638 To treat diseases of lipid metabolism, cardiovascular disease, inflammatory diseases; selective agonists of the nicotinic acid receptor; 2-{[(4-Biphenylyloxy)acetyl]amino}-4-(methyloxy)benzoic acid
09/04/2008US20080213347 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
09/03/2008EP1964843A1 Process for production of water-soluble azole prodrug
09/03/2008EP1963256A1 Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure
09/03/2008EP1311480B1 New amidino derivatives and their use as thrombin inhibitors
09/03/2008EP1257541B1 Polypharmacophoric agents
09/03/2008CN101255121A Preparation technique of lysine rhein and use thereof in tumour therapy
09/03/2008CN101255120A Novel technique for extracting glutaminic acid with low material consumption and water waste
09/03/2008CN101255117A Non-steroidal antiphlogiston prodrug with nitric oxide donor and preparation method thereof
09/03/2008CN100415753C 4-dimethylamino crotonic acid, its derivatives and their preparing method
09/02/2008US7420087 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
09/02/2008US7420085 Form II; used for facilitating the delivery of active agents, such as insulin, to a target
09/02/2008US7420084 Polymorphic forms of nateglinide
09/02/2008US7420079 Intermediates for making 1(alpha-amino-1-(cyclopropyl-fused pyrrolidinylcarbonyl)methyl)-3-hydroxyadamantanes, e.g., methyl 3-hydroxy-<a-oxotricyclo[3.3.1.13,7]decane-1-acetate
09/02/2008US7420078 Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof
09/02/2008US7420071 Thermally stable surfactants and compositions and methods of use thereof
09/02/2008US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
09/02/2008US7419974 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same
09/02/2008US7419933 chiral zirconium catalyst that can maintain its high catalytic activity even after long-term storage, which is stable in air and storable for a long period of time, and recoverable and reusable after reaction, is provided.
08/2008
08/28/2008WO2008103319A2 Compounds and methods for use in detecting gabapentin
08/28/2008WO2008102671A1 Method for purifying 4-hydroxyisoleucine
08/28/2008WO2008101608A1 Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt
08/28/2008WO2008083967A3 Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
08/28/2008WO2007137008A3 Compounds for the treatment of metabolic disorders
08/28/2008US20080207942 Using in coordination catalyst containing transition metal for hydrogenation, phase transfer, cyanation,borating, hydrosilylation
08/28/2008US20080207776 Lipid aggregate for delivery of macromolecules into cells
08/28/2008US20080207529 Isolated Dipeptides with Ace Inhibitor Effect
08/28/2008US20080206820 activated ester of the carboxyl-containing compound (carboxylic acid) is reacted with H217O or H218O in the presence of an activator; labelled amino acid
08/28/2008US20080206805 Compounds and Related Methods for Mutant p53 Reactivation
08/28/2008DE19681399B4 Verfahren zur Herstellung von 5-Amino-2,4,6-triiodisophthalsäuredichlorid durch Chlorierung mit Thionylchlorid in Anwesenheit eines Katalysators Process for the preparation of 5-amino-2,4,6-triiodoisophthalic acid dichloride by chlorination with thionyl chloride in the presence of a catalyst
08/28/2008CA2679159A1 Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt
08/28/2008CA2678990A1 Method for purifying 4-hydroxyisoleucine
08/27/2008EP1961735A1 Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt
08/27/2008EP1961728A1 Method for producing optically active (4e)-5-chloro-2-isopropyl-4-pentenoic acid or basic amino acid salt thereof
08/27/2008EP1959948A2 Levodopa prodrug mesylate, compositions thereof, and uses thereof
08/27/2008CN101253146A Novel derivatives of amino acids for treatment of obesity and related disorders
08/27/2008CN101250129A Method for preparing alpha-decyl betaine amphoteric surfactant
08/27/2008CN100413844C Multiple photon absorptive phenyl fluorene derivative and its preparing method
08/26/2008US7417166 Process for the preparation of gabapentin
08/26/2008US7417060 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid
08/26/2008US7417022 Amino acid for deliverying active materials; bioavailability
08/21/2008WO2008100423A1 Gut microsomal triglyceride transport protein inhibitors
08/21/2008WO2008099800A1 Method for production of radiation diagnostic imaging agent
08/21/2008WO2008099730A1 Method for production of amine compound using optically active 2-(aroyloxy)propionic acid
08/21/2008WO2007089745A3 Novel compounds with high therapeutic index
08/21/2008WO2007072159B1 Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
08/21/2008US20080200723 Creatine-fatty acids
08/21/2008US20080200705 Enhanced bioavailability; forming creatine from fatty acid and thionyl halide; amidation
08/21/2008US20080200521 Novel hydroxamic acid containing amino acid derivatives
08/21/2008US20080199922 Deacylation of 5-cyanophthalide via esterases from Aspergillus
08/21/2008US20080199887 Compounds and methods for use in detecting gabapentin
08/21/2008CA2678020A1 Method for production of radiation diagnostic imaging agent
08/20/2008EP1959029A1 Palladium complex and catalyst-imparting treatment solution using the same
08/20/2008EP1957441A2 Intermediate compounds for the preparation of statins
08/20/2008EP1778624B1 Tyrosine derivatives as ppar-gamma-modulators
08/20/2008EP1459765B1 6-fluorobicyclo 3.1.0 hexane derivatives
08/20/2008EP0703897B1 Lipoxin compounds with prolonged half-life
08/20/2008CN101245032A Leuco malachite green hapten, produced antibody and application of the antibody
08/20/2008CN100412053C Process for phenylacetic acid derivatives
08/20/2008CN100412052C Technique of water phase method for preparing Mono-SGC
08/20/2008CA2621925A1 Preparation of amino acid-fatty acid anhydrides
08/19/2008US7414040 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia
08/19/2008CA2367364C Process for nitrating aniline derivatives
08/19/2008CA2310714C Process for preparing neuraminidase inhibitor ro-64-0796
08/14/2008WO2008096760A1 NOVEL HEXATRIENE-β-CARBONYL COMPOUND
08/14/2008WO2008076707A3 Triamine/aspartate curative and coatings comprising the same
08/14/2008US20080194873 Method For Producing Methylglycine-N,N-Diethanoic Acid-Trialkali Metal Salts With A Low By-Product Content
08/14/2008US20080194872 Attaching to purification matrix via cyclizing with aldehyde or ketone groups (capture tags) wherein the capture tag is cleavable from the polypeptide, washing, then releasing
08/14/2008US20080194867 Nateglinide crystals
08/14/2008US20080194859 Compounds useful in formation of polyureas with increased toughness and durability without a significant loss of flexibility of the material, improved stability, including UV stability, and/or utility for microbial or other biofouling in underwater applications
08/14/2008US20080194841 Preparation of Optically Pure Beta-Amino Acids Having Affinity for the Alpha-Delta Protein
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 215